Abstract Adoptive cell transfer using chimeric antigen receptors (CAR) has emerged as one of the most promising new therapeutic modalities for patients with relapsed or refractory B-cell malignancies. Thus far, results in patients with advanced solid tumors have proven disappointing. Constitutive to...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!